SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic evaluation of sevelamer in patients with end-stage renal disease
16 references·1 citing·41 second hop
Economic evaluation of sevelamer in patients with end-stage renal disease (2007)Economic evaluation of sevelamer in patie…Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Representing uncertainty: the…Testing the Validity of Cost-Effectiveness Models (2000)Testing the Validity of Cost-…Assessing Quality in Decision Analytic Cost-Effectiveness Models (2000)Assessing Quality in Decision…The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)The irrelevance of inference:…Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane (1998)Confidence intervals or surfa…Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials? (1996)Economic evaluation of pharma…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …A study of the quality of life and cost-utility of renal transplantation (1996)A study of the quality of lif…Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis (1994)Uncertainty in the economic e…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Setting health care priorities in Oregon. (1991)Setting health care prioritie…Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue (1991)Setting health care prioritie…Setting Health Care Priorities in Oregon (1991)Setting Health Care Prioritie…Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation (1986)Probabilistic Analysis of Dec…Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Probabilistic Sensitivity Ana…Economic Evaluation of Frequent Home Nocturnal Hemodialysis Based on a Randomized Controlled Trial (2013)Economic Evaluation of Freque…A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)Meta-Analyses of Randomized Controlled Trials (1987)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Multiattribute Utility Function for a Comprehensive Health Status Classification System (1996)Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Judgment under Uncertainty: Heuristics and Biases (1974)Clinical Decision Analysis (1980)Handling Uncertainty in Cost-Effectiveness Models (2000)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)Methods for the economic evaluation of health care programmes (1987)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Generalisability in economic evaluation studies in healthcare: a review and case studies (2004)Interpreting the Results of Cost-Effectiveness Studies (2008)Preference and Urgency (1975)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)A general health policy model: update and applications. (1988)A review of the use of health status measures in economic evaluation. (1999)Incorporating societal concerns for fairness in numerical valuations of health programmes (1999)Cost-Effectiveness Analysis and the Consistency of Decision Making (2001)The Sickness Impact Profile: Development and Final Revision of a Health Status Measure (1981)One Thousand Health-Related Quality-of-Life Estimates (2000)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments (2012)Regret Theory: An Alternative Theory of Rational Choice Under Uncertainty (1982)Net Health Benefits (1998)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Definition, interpretation and calculation of cost-effectiveness acceptability curves (2000)Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data (2003)Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility (2004)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,170 cited
  • 1996A study of the quality of life and cost-utility of renal transplantation1,167 cited
  • 2001Representing uncertainty: the role of cost‐effectiveness acceptability curves1,111 cited
  • 1999The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies891 cited
  • 1985Probabilistic Sensitivity Analysis Using Monte Carlo Simulation860 cited
  • 1994Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis521 cited
  • 1991Setting Health Care Priorities in Oregon441 cited
  • 1998Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane397 cited
  • 2000Assessing Quality in Decision Analytic Cost-Effectiveness Models212 cited
  • 1986Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation198 cited
  • 1996Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?115 cited
  • 1991

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue
109 cited
  • 2000Testing the Validity of Cost-Effectiveness Models95 cited
  • 1991Setting health care priorities in Oregon.92 cited
  • Cited by

    • 2013Economic Evaluation of Frequent Home Nocturnal Hemodialysis Based on a Randomized Controlled Trial69 cited